ScoreWhy is HPGC Renmintongtai Pharmaceutical Corp. ?
1
Poor Management Efficiency with a low ROCE of 9.08%
- The company has been able to generate a Return on Capital Employed (avg) of 9.08% signifying low profitability per unit of total capital (equity and debt)
2
The company is Net-Debt Free
- Poor long term growth as Net Sales has grown by an annual rate of 4.90% and Operating profit at 0.01% over the last 5 years
- The company is Net-Debt Free
- The company has been able to generate a Return on Equity (avg) of 9.49% signifying low profitability per unit of shareholders funds
3
Poor long term growth as Net Sales has grown by an annual rate of 4.90% and Operating profit at 0.01% over the last 5 years
4
Flat results in Jun 26
- INTEREST(Q) Highest at CNY 7.36 MM
5
With ROE of 4.45%, it has a fair valuation with a 1.47 Price to Book Value
- Over the past year, while the stock has generated a return of 26.88%, its profits have fallen by -24.5%
- At the current price, the company has a high dividend yield of 0
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is HPGC Renmintongtai Pharmaceutical Corp. for you?
High Risk, High Return
Absolute
Risk Adjusted
Volatility
HPGC Renmintongtai Pharmaceutical Corp.
21.77%
1.07
64.41%
China Shanghai Composite
0.9%
0.22
14.72%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
4.90%
EBIT Growth (5y)
0.01%
EBIT to Interest (avg)
10.44
Debt to EBITDA (avg)
3.08
Net Debt to Equity (avg)
0.47
Sales to Capital Employed (avg)
2.04
Tax Ratio
29.55%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
8.55%
ROE (avg)
9.49%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
33
Industry P/E
Price to Book Value
1.47
EV to EBIT
24.24
EV to EBITDA
20.28
EV to Capital Employed
1.35
EV to Sales
0.53
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
5.56%
ROE (Latest)
4.45%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
Mildly Bullish
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend1What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -2.5% (YoY
-3What is not working for the Company
INTEREST(Q)
Highest at CNY 7.36 MM
Here's what is working for HPGC Renmintongtai Pharmaceutical Corp.
Raw Material Cost
Fallen by -2.5% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for HPGC Renmintongtai Pharmaceutical Corp.
Interest
At CNY 7.36 MM has Grown at 32.2%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest
Highest at CNY 7.36 MM
in the last five periods and Increased by 32.2% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Footer loading
